What happened
Shares of Novavax(NASDAQ:NVAX) plunged 19.6% on Friday after the biotech delayed its plans to seek emergency use authorization for its coronavirus vaccine candidate.
So what
Novavax had previously hoped to obtain regulatory clearance by May,…
